• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用脑转移磁共振影像组学预测非小细胞肺癌(NSCLC)中的T790M突变:一项针对不均衡数据集的研究

Predicting the T790M mutation in non-small cell lung cancer (NSCLC) using brain metastasis MR radiomics: a study with an imbalanced dataset.

作者信息

Wu Wen-Feng, Lai Kuan-Ming, Chen Chia-Hung, Wang Bai-Chuan, Chen Yi-Jen, Shen Chia-Wei, Chen Kai-Yan, Lin Eugene C, Chen Chien-Chin

机构信息

Department of Radiology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, 600, Taiwan.

Central Taiwan University of Science and Technology Institute of Radiological Science, Taichung, 406, Taiwan.

出版信息

Discov Oncol. 2024 Sep 14;15(1):447. doi: 10.1007/s12672-024-01333-1.

DOI:10.1007/s12672-024-01333-1
PMID:39277568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11401825/
Abstract

BACKGROUND

Early detection of T790M mutation in exon 20 of epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC) patients with brain metastasis is crucial for optimizing treatment strategies. In this study, we developed radiomics models to distinguish NSCLC patients with T790M-positive mutations from those with T790M-negative mutations using multisequence MR images of brain metastasis despite an imbalanced dataset. Various resampling techniques and classifiers were employed to identify the most effective strategy.

METHODS

Radiomic analyses were conducted on a dataset comprising 125 patients, consisting of 18 with EGFR T790M-positive mutations and 107 with T790M-negative mutations. Seventeen first- and second-order statistical features were selected from CET1WI, T2WI, T2FLAIR, and DWI images. Four classifiers (logistic regression, support vector machine, random forest [RF], and extreme gradient boosting [XGBoost]) were evaluated under 13 different resampling conditions.

RESULTS

The area under the curve (AUC) value achieved was 0.89, using the SVM-SMOTE oversampling method in combination with the XGBoost classifier. This performance was measured against the AUC reported in the literature, serving as an upper-bound reference. Additionally, comparable results were observed with other oversampling methods paired with RF or XGBoost classifiers.

CONCLUSIONS

Our study demonstrates that, even when dealing with an imbalanced EGFR T790M dataset, reasonable predictive outcomes can be achieved by employing an appropriate combination of resampling techniques and classifiers. This approach has significant potential for enhancing T790M mutation detection in NSCLC patients with brain metastasis.

摘要

背景

对于非小细胞肺癌(NSCLC)脑转移患者,早期检测表皮生长因子受体(EGFR)第20外显子中的T790M突变对于优化治疗策略至关重要。在本研究中,我们开发了放射组学模型,尽管数据集不均衡,但仍使用脑转移的多序列MR图像来区分T790M阳性突变的NSCLC患者和T790M阴性突变的患者。采用了各种重采样技术和分类器来确定最有效的策略。

方法

对包含125例患者的数据集进行放射组学分析,其中18例为EGFR T790M阳性突变,107例为T790M阴性突变。从CET1WI、T2WI、T2FLAIR和DWI图像中选择了17个一阶和二阶统计特征。在13种不同的重采样条件下评估了四种分类器(逻辑回归、支持向量机、随机森林[RF]和极端梯度提升[XGBoost])。

结果

使用支持向量机-合成少数过采样技术(SVM-SMOTE)过采样方法结合XGBoost分类器获得的曲线下面积(AUC)值为0.89。该性能是与文献中报道的AUC进行比较来衡量的,作为上限参考。此外,使用其他过采样方法与RF或XGBoost分类器配对时也观察到了类似的结果。

结论

我们的研究表明,即使处理不均衡的EGFR T790M数据集,通过采用重采样技术和分类器的适当组合也可以实现合理的预测结果。这种方法在增强NSCLC脑转移患者的T790M突变检测方面具有巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/11401825/283b4eec3eaa/12672_2024_1333_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/11401825/d6889ae24491/12672_2024_1333_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/11401825/d16df84c9e26/12672_2024_1333_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/11401825/283b4eec3eaa/12672_2024_1333_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/11401825/d6889ae24491/12672_2024_1333_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/11401825/d16df84c9e26/12672_2024_1333_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/11401825/283b4eec3eaa/12672_2024_1333_Fig3_HTML.jpg

相似文献

1
Predicting the T790M mutation in non-small cell lung cancer (NSCLC) using brain metastasis MR radiomics: a study with an imbalanced dataset.利用脑转移磁共振影像组学预测非小细胞肺癌(NSCLC)中的T790M突变:一项针对不均衡数据集的研究
Discov Oncol. 2024 Sep 14;15(1):447. doi: 10.1007/s12672-024-01333-1.
2
Predicting EGFR T790M Mutation in Brain Metastases Using Multisequence MRI-Based Radiomics Signature.基于多序列 MRI 影像组学特征预测脑转移瘤中的 EGFR T790M 突变。
Acad Radiol. 2023 Sep;30(9):1887-1895. doi: 10.1016/j.acra.2022.12.030. Epub 2022 Dec 30.
3
Machine Learning-Based CT Radiomics Analysis for Prognostic Prediction in Metastatic Non-Small Cell Lung Cancer Patients With -T790M Mutation Receiving Third-Generation EGFR-TKI Osimertinib Treatment.基于机器学习的CT影像组学分析在接受第三代EGFR-TKI奥希替尼治疗的伴有T790M突变的转移性非小细胞肺癌患者预后预测中的应用
Front Oncol. 2021 Sep 29;11:719919. doi: 10.3389/fonc.2021.719919. eCollection 2021.
4
A Radiomics-clinical Nomogram based on CT Radiomics to Predict Acquired T790M Mutation Status in Non-small Cell Lung Cancer Patients.基于CT影像组学的影像组学-临床列线图预测非小细胞肺癌患者获得性T790M突变状态
Curr Med Imaging. 2024 Mar 22. doi: 10.2174/0115734056283623240215102037.
5
Prediction of EGFR Mutation Status in Non-Small Cell Lung Cancer Based on Ensemble Learning.基于集成学习的非小细胞肺癌中表皮生长因子受体突变状态的预测
Front Pharmacol. 2022 Jun 27;13:897597. doi: 10.3389/fphar.2022.897597. eCollection 2022.
6
Multisequence MRI-based radiomics analysis for early prediction of the risk of T790M resistance in new brain metastases.基于多序列MRI的影像组学分析用于早期预测新发性脑转移中T790M耐药风险
Quant Imaging Med Surg. 2023 Dec 1;13(12):8599-8610. doi: 10.21037/qims-23-822. Epub 2023 Oct 20.
7
Preoperative MRI-Based Radiomics of Brain Metastasis to Assess T790M Resistance Mutation After EGFR-TKI Treatment in NSCLC.基于术前MRI的脑转移瘤放射组学评估非小细胞肺癌EGFR-TKI治疗后T790M耐药突变
J Magn Reson Imaging. 2023 Jun;57(6):1778-1787. doi: 10.1002/jmri.28441. Epub 2022 Sep 27.
8
Brain-Tumor Interface-Based MRI Radiomics Models to Determine EGFR Mutation, Response to EGFR-TKI and T790M Resistance Mutation in Non-Small Cell Lung Carcinoma Brain Metastasis.基于脑肿瘤界面的 MRI 影像组学模型预测非小细胞肺癌脑转移患者表皮生长因子受体突变、表皮生长因子受体酪氨酸激酶抑制剂治疗反应及 T790M 耐药突变
J Magn Reson Imaging. 2023 Dec;58(6):1838-1847. doi: 10.1002/jmri.28751. Epub 2023 May 5.
9
CT Radiomics Predict EGFR-T790M Resistance Mutation in Advanced Non-Small Cell Lung Cancer Patients After Progression on First-line EGFR-TKI.CT影像组学预测一线EGFR-TKI治疗进展后晚期非小细胞肺癌患者的EGFR-T790M耐药突变
Acad Radiol. 2023 Nov;30(11):2574-2587. doi: 10.1016/j.acra.2023.01.040. Epub 2023 Mar 21.
10
Machine learning-based radiomics strategy for prediction of acquired EGFR T790M mutation following treatment with EGFR-TKI in NSCLC.基于机器学习的放射组学策略预测 NSCLC 患者接受 EGFR-TKI 治疗后获得性 EGFR T790M 突变。
Sci Rep. 2024 Jan 3;14(1):446. doi: 10.1038/s41598-023-50984-7.

引用本文的文献

1
Comparison of Resampling Methods and Radiomic Machine Learning Classifiers for Predicting Bone Quality Using Dual-Energy X-Ray Absorptiometry.使用双能X线吸收法预测骨质量的重采样方法与放射组学机器学习分类器的比较
Diagnostics (Basel). 2025 Jan 14;15(2):175. doi: 10.3390/diagnostics15020175.

本文引用的文献

1
Predicting EGFR T790M Mutation in Brain Metastases Using Multisequence MRI-Based Radiomics Signature.基于多序列 MRI 影像组学特征预测脑转移瘤中的 EGFR T790M 突变。
Acad Radiol. 2023 Sep;30(9):1887-1895. doi: 10.1016/j.acra.2022.12.030. Epub 2022 Dec 30.
2
Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer.非小细胞肺癌中的表皮生长因子受体突变与脑转移
Front Oncol. 2022 Nov 15;12:912505. doi: 10.3389/fonc.2022.912505. eCollection 2022.
3
Dynamic Assessment of Tissue and Plasma -Activating and T790M Mutations with Droplet Digital PCR Assays for Monitoring Response and Resistance in Non-Small Cell Lung Cancers Treated with EGFR-TKIs.
采用液滴数字 PCR 分析检测组织和血浆中激活和 T790M 突变,动态评估非小细胞肺癌患者接受 EGFR-TKIs 治疗的反应和耐药情况。
Int J Mol Sci. 2022 Sep 26;23(19):11353. doi: 10.3390/ijms231911353.
4
Preoperative MRI-Based Radiomics of Brain Metastasis to Assess T790M Resistance Mutation After EGFR-TKI Treatment in NSCLC.基于术前MRI的脑转移瘤放射组学评估非小细胞肺癌EGFR-TKI治疗后T790M耐药突变
J Magn Reson Imaging. 2023 Jun;57(6):1778-1787. doi: 10.1002/jmri.28441. Epub 2022 Sep 27.
5
Role of intratumoral and peritumoral CT radiomics for the prediction of EGFR gene mutation in primary lung cancer.肿瘤内和肿瘤周围 CT 放射组学在预测原发性肺癌中 EGFR 基因突变中的作用。
Br J Radiol. 2022 Dec 1;95(1140):20220374. doi: 10.1259/bjr.20220374. Epub 2022 Sep 26.
6
Differentiating EGFR from ALK mutation status using radiomics signature based on MR sequences of brain metastasis.基于脑转移瘤磁共振序列的影像组学特征区分 EGFR 与 ALK 突变状态。
Eur J Radiol. 2022 Oct;155:110499. doi: 10.1016/j.ejrad.2022.110499. Epub 2022 Aug 27.
7
Radiomic Signatures for Predicting Mutation Status in Lung Cancer Brain Metastases.预测肺癌脑转移突变状态的影像组学特征
Front Oncol. 2022 Jul 14;12:931812. doi: 10.3389/fonc.2022.931812. eCollection 2022.
8
Radiomics evaluates the EGFR mutation status from the brain metastasis: a multi-center study.从脑转移瘤评估 EGFR 突变状态的放射组学:一项多中心研究。
Phys Med Biol. 2022 Jun 8;67(12). doi: 10.1088/1361-6560/ac7192.
9
Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance.肺癌脑转移与原发肿瘤受体表达不一致的系统评价和荟萃分析
Discov Oncol. 2021 Nov 8;12(1):48. doi: 10.1007/s12672-021-00445-2.
10
Value of radiomics model based on multi-parametric magnetic resonance imaging in predicting epidermal growth factor receptor mutation status in patients with lung adenocarcinoma.基于多参数磁共振成像的影像组学模型在预测肺腺癌患者表皮生长因子受体突变状态中的价值。
J Thorac Dis. 2021 Jun;13(6):3497-3508. doi: 10.21037/jtd-20-3358.